0%
0%
0%
0%
0%
About Eagle Pharmaceuticals, Inc
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Scott L. Tarriff
Website
eagleus.com
Headquarters
Woodcliff Lake
Employees
135
Founded
2007
ISIN
US2697961082
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
EGRX ShortNice rounded top in EGRX... Liking a short here on this one as well. If it breaks through that support around $35 we could see a nice plunge.
$EGRX on Be prepared for possible GrowthAs Eagle Pharma Win Patent Decision for Bendeka, Court issued a favorable patent decision for Bendeka bendamustine hydrochloride injection, or bendamustine HCl , a liquid, low-volume and short-time 10-minute infusion formulation of bendamustine hydrochloride. So with that $EGRX shares rose 23% to $6
Eagle Pharmaceuticals on verge of breakout. Price entry $60 - target price $ 66 stop loss $58
Despite the stock been above the average analysts target we remain bullish om the setup technically, there is also the chance of upgrades to follow.
P/E ratio 20.65
Short interest 14.62 % Quite High, but normal in the Pharma sector.
EAGLE PHARMA ready to break out. ===============
SHORT TERM PRICE TARGET $68 +15% UPSIDE
===============
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on
EGRX flag break, looking for a follow through higher This just recently broke out of a flag pattern, so I'm going long tomorrow watching if it can keep going higher.
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
